Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risedronate for bone loss in prostate cancer
NCT00859027Phase 4Completed
- Sponsor
- UConn Health
- Start
- Jan 2003
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risedronate in osteoporosis, sponsored by UConn Health. Started Jan 2003; status: completed.
02
Drugs
risedronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00859027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00859027.